328
Views
72
CrossRef citations to date
0
Altmetric
Review

Effect of the protein corona on nanoparticles for modulating cytotoxicity and immunotoxicity

, , , &
Pages 97-113 | Published online: 18 Dec 2014

References

  • DeMGhoshPRotelloVApplications of nanoparticles in biologyAdv Mater20082042254241
  • FerrariMCancer nanotechnology: opportunities and challengesNat Rev Cancer20055316117115738981
  • StephanMTMoonJJUmSHBershteynAIrvineDJTherapeutic cell engineering with surface-conjugated synthetic nanoparticlesNat Med20101691035104120711198
  • ZhangLGuFXChanJMWangAZLangerRSFarokhzadOCNanoparticles in medicine: therapeutic applications and developmentsClin Pharmacol Ther200883576176917957183
  • MauseSFWeberCMicroparticles: protagonists of a novel communication network for intercellular information exchangeCirc Res201010791047105721030722
  • RakJMicroparticles in cancerSemin Thromb Hemost201036888890621049390
  • GrefRMinamitakeYPeracchiaMTTrubetskoyVTorchilinVLangerRBiodegradable long-circulating polymeric nanospheresScience19942635153160016038128245
  • GöppertTMMüllerRHPolysorbate-stabilized solid lipid nanoparticles as colloidal carriers for intravenous targeting of drugs to the brain: comparison of plasma protein adsorption patternsJ Drug Target200513317918716036306
  • WalczykDBombelliFBMonopoliMPLynchIDawsonKAWhat the cell “sees” in bionanoscienceJ Am Chem Soc2010132165761576820356039
  • YanYGauseKTKamphuisMMDifferential roles of the protein corona in the cellular uptake of nanoporous polymer particles by monocyte and macrophage cell linesACS Nano201323:712109601097024256422
  • LeuDMantheyBKreuterJSpeiserPDeLucaPPDistribution and elimination of coated polymethyl [2–14C]methacrylate nanoparticles after intravenous injection in ratsJ Pharm Sci19847310143314376502493
  • BalaIHariharanSKumarMNPLGA nanoparticles in drug delivery: the state of the artCrit Rev Ther Drug Carrier Syst200421538742215719481
  • LesniakAFenaroliFMonopoliMPÅbergCDawsonKASalvatiAEffects of the presence or absence of a protein corona on silica nanoparticle uptake and impact on cellsACS Nano2012675845585722721453
  • LesniakASalvatiASantos-MartinezMJRadomskiMWDawsonKAÅbergCNanoparticle adhesion to the cell membrane and its effect on nanoparticle uptake efficiencyJ Am Chem Soc201313541438144423301582
  • TreuelLBrandholtSMaffrePWiegeleSShangLNienhausGUImpact of protein modification on the protein corona on nanoparticles and nanoparticle-cell interactionsACS Nano20148150351324377255
  • HuWPengCLvMProtein corona-mediated mitigation of cytotoxicity of graphene oxideACS Nano2011553693370021500856
  • YangSTLiuYWangYWCaoABiosafety and bioapplication of nanomaterials by designing protein-nanoparticle interactionsSmall201399–101635165323341247
  • WalkeyCDChanWCUnderstanding and controlling the interaction of nanomaterials with proteins in a physiological environmentChem Soc Rev20124172780279922086677
  • FenoglioIFubiniBGhibaudiEMTurciFMultiple aspects of the interaction of biomacromolecules with inorganic surfacesAdv Drug Deliv Rev201163131186120921871508
  • MonopoliMPAbergCSalvatiADawsonKABiomolecular coronas provide the biological identity of nanosized materialsNat Nanotechnol201271277978623212421
  • NelAEMädlerLVelegolDUnderstanding biophysicochemical interactions at the nano-bio interfaceNat Mater20098754355719525947
  • WangXReeceSPBrownJMImmunotoxicological impact of engineered nanomaterial exposure: mechanisms of immune cell modulationToxicol Mech Methods201323316817723256453
  • KarmaliPPSimbergDInteractions of nanoparticles with plasma proteins: implication on clearance and toxicity of drug delivery systemsExpert Opin Drug Deliv20118334335721291354
  • CedervallTLynchILindmanSUnderstanding the nanoparticle-protein corona using methods to quantify exchange rates and affinities of proteins for nanoparticlesProc Natl Acad Sci U S A200710472050205517267609
  • MonopoliMPWalczykDCampbellAPhysical-chemical aspects of protein corona: relevance to in vitro and in vivo biological impacts of nanoparticlesJ Am Chem Soc201113382525253421288025
  • PeracchiaMTHarnischSPinto-AlphandaryHVisualization of in vitro protein-rejecting properties of PEGylated stealth polycyanoacrylate nanoparticlesBiomaterials199920141269127510403044
  • GrefRLückMQuellecP‘Stealth’ corona-core nanoparticles surface modified by polyethylene glycol (PEG): influences of the corona (PEG chain length and surface density) and of the core composition on phagocytic uptake and plasma protein adsorptionColloids Surf B Biointerfaces2000183–430131310915952
  • GessnerAWaiczRLieskeAPaulkeBMäderKMüllerRHNanoparticles with decreasing surface hydrophobicities: influence on plasma protein adsorptionInt J Pharm2000196224524910699728
  • GessnerALieskeAPaulkeBRMüllerRHFunctional groups on polystyrene model nanoparticles: influence on protein adsorptionJ Biomed Mater Res A200365331932612746878
  • LacerdaSHParkJJMeuseCInteraction of gold nanoparticles with common human blood proteinsACS Nano20104136537920020753
  • CasalsEPfallerTDuschlAOostinghGJPuntesVTime evolution of the nanoparticle protein coronaACS Nano2010473623363220553005
  • MiclăuşTBochenkovVEOgakiRHowardKASutherlandDSSpatial mapping and quantification of soft and hard protein coronas at silver nanocubesNano Lett20141442086209324617413
  • MedintzILKonnertJHClappARA fluorescence resonance energy transfer-derived structure of a quantum dot-protein bioconjugate nanoassemblyProc Natl Acad Sci U S A2004101269612961715210939
  • Aubin-TamMEHamad-SchifferliKGold nanoparticle-cytochrome C complexes: the effect of nanoparticle ligand charge on protein structureLangmuir20052126120801208416342975
  • RoachPFarrarDPerryCCSurface tailoring for controlled protein adsorption: effect of topography at the nanometer scale and chemistryJ Am Chem Soc2006128123939394516551101
  • LundqvistMStiglerJEliaGLynchICedervallTDawsonKANanoparticle size and surface properties determine the protein corona with possible implications for biological impactsProc Natl Acad Sci U S A200810538142651427018809927
  • TenzerSDocterDKuharevJRapid formation of plasma protein corona critically affects nanoparticle pathophysiologyNat Nanotechnol201381077278124056901
  • De PaoliSHDiduchLLTegegnTZThe effect of protein corona composition on the interaction of carbon nanotubes with human blood plateletsBiomaterials201435246182619424831972
  • HühnDKantnerKGeidelCPolymer-coated nanoparticles interacting with proteins and cells: focusing on the sign of the net chargeACS Nano2013743253326323566380
  • LacerdaLBiancoAPratoMKostarelosKCarbon nanotubes as nanomedicines: from toxicology to pharmacologyAdv Drug Deliv Rev200658141460147017113677
  • LiuZRobinsonJTTabakmanSMYangKDaiHCarbon materials for drug delivery and cancer therapyMater Today2011147–8316323
  • CaiXRamalingamRWongHSCharacterization of carbon nanotube protein corona by using quantitative proteomicsNanomedicine (Lond)201395583593
  • GeCDuJZhaoLBinding of blood proteins to carbon nanotubes reduces cytotoxicityProc Natl Acad Sci U S A201110841169681697321969544
  • ZhuYLiWLiQEffects of serum proteins on intracellular uptake and cytotoxicity of carbon nanoparticlesCarbon200947513511358
  • ParkSJKhangDConformational changes of fibrinogen in dispersed carbon nanotubesInt J Nanomedicine201274325433322915854
  • MaoHYLaurentSChenWGraphene: promises, facts, opportunities, and challenges in nanomedicineChem Rev201311353407342423452512
  • MaoHChenWLaurentSHard corona composition and cellular toxicities of the graphene sheetsColloids Surf B Biointerfaces201310921221823643918
  • LemarchandCGrefRPassiraniCInfluence of polysaccharide coating on the interactions of nanoparticles with biological systemsBiomaterials200627110811816118015
  • CasalsEPfallerTDuschlAOostinghGJPuntesVFHardening of the nanoparticle-protein corona in metal (Au, Ag) and oxide (Fe3O4, CoO, and CeO2) nanoparticlesSmall20117243479348622058075
  • Braydich-StolleLHussainSSchlagerJJHofmannMCIn vitro cytotoxicity of nanoparticles in mammalian germline stem cellsToxicol Sci200588241241916014736
  • AshaRaniPVLow Kah MunGHandeMPValiyaveettilSCytotoxicity and genotoxicity of silver nanoparticles in human cellsACS Nano20093227929019236062
  • KittlerSGreulichCDiendorfJKöllerMEppleMToxicity of Silver Nanoparticles Increases during Storage Because of Slow Dissolution under Release of Silver IonsChem Mater2010221645484554
  • MaioranoGSabellaSSorceBBrunettiVMalvindiMACingolaniRPompaPPEffects of cell culture media on the dynamic formation of protein-nanoparticle complexes and influence on the cellular responseACS Nano20104127481749121082814
  • LynchISalvatiADawsonKAProtein-nanoparticle interactions: What does the cell see?Nat Nanotechnol20094954654719734922
  • MüllerKHMotskinMPhilpottAJThe effect of particle agglomeration on the formation of a surface-connected compartment induced by hydroxyapatite nanoparticles in human monocyte-derived macrophagesBiomaterials20143531074108824183166
  • MotskinMMüllerKHGenoudCMonteithAGSkepperJNThe sequestration of hydroxyapatite nanoparticles by human monocyte-macrophages in a compartment that allows free diffusion with the extracellular environmentBiomaterials201132359470948221889202
  • SalmonJEKapurSKimberlyRPOpsonin-independent ligation of Fc gamma receptors. The 3G8-bearing receptors on neutrophils mediate the phagocytosis of concanavalin A-treated erythrocytes and nonopsonized Escherichia coliJ Exp Med19871666179818132445895
  • HarashimaHSakataKFunatoKKiwadaHEnhanced hepatic uptake of liposomes through complement activation depending on the size of liposomesPharm Res19941134024068008707
  • LerouxJCDe JaeghereFAnnerBDoelkerEGurnyRAn investigation on the role of plasma and serum opsonins on the internalization of biodegradable poly(D,L-lactic acid) nanoparticles by human monocytesLife Sci19955776957037637541
  • SimRBTsiftsoglouSAProteases of the complement systemBiochem Soc Trans200432Pt 1212714748705
  • Rybak-SmithMJSim RB; Rybak-SmithMJComplement activation by carbon nanotubesAdv Drug Deliv Rev201163121031104121669239
  • BertholonIVauthierCLabarreDComplement activation by core-shell poly(isobutylcyanoacrylate)-polysaccharide nanoparticles: influences of surface morphology, length, and type of polysaccharidePharm Res20062361313132316715369
  • HulanderMLundgrenABerglinMOhrlanderMLausmaaJElwingHImmune complement activation is attenuated by surface nanotopographyInt J Nanomedicine201162653266622114496
  • GorbetMBSeftonMVBiomaterial-associated thrombosis: roles of coagulation factors, complement, platelets and leukocytesBiomaterials200425265681570315147815
  • Salvador-MoralesCFlahautESimESloanJGreenMLSimRBSalvador-MoralesCComplement activation and protein adsorption by carbon nanotubesMol Immunol200643319320116199256
  • KouserLAbdul-AzizMNayakAStoverCMSimRBKishoreUProperdin and factor h: opposing players on the alternative complement pathway “see-saw”Front Immunol201349323630525
  • HorbettTChapter 13 Principles underlying the role of adsorbed plasma proteins in blood interactions with foreign materialsCardiovasc Pathol199323137148
  • ChinnJAHorbettTARatnerBDBaboon fibrinogen adsorption and platelet adhesion to polymeric materialsThromb Haemost19916556086171871724
  • LishkoVKPodolnikovaNPYakubenkoVPMultiple binding sites in fibrinogen for integrin alphaMbeta2 (Mac-1)J Biol Chem200422;279434489744906
  • DingZMBabenseeJESimonSIRelative contribution of LFA-1 and Mac-1 to neutrophil adhesion and migrationJ Immunol199916395029503810528208
  • DengZJLiangMMonteiroMTothIMinchinRFNanoparticle-induced unfolding of fibrinogen promotes Mac-1 receptor activation and inflammationNat Nanotechnol201161394421170037